Nephron Pharmaceuticals Corporation CEO Lou Kennedy (far right) conducts a tour for Capital
Rotary Club members during a field trip to the 408,000 square foot West Columbia facility.
Though still in start-up stages, Nephron represents a $313 million investment and presently has
over 100 employees. It will manufacture and distribute respiratory products, eye drops that
are preservative and additive free, sterile injectable drugs and oral vaccines. Capital Rotary
periodically tours various points of interest throughout the community.